Paper · 39391981
Atractylodes Lancea and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK Activation.
Song GY and 4 others. Biomol Ther (Seoul), 2024. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Atractylodes Lancea and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK Activation. Papers, record 39391981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39391981
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Atractylodes Lancea and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK Activation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33,579,265 | A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects. | BMC Complement Med Ther | 2021 | https://conductscience.org/library/papers/33579265 | PubMed |
| 2 | 16,950,137 | Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. | Cell Metab | 2006 | https://conductscience.org/library/papers/16950137 | PubMed |
| 3 | 28,355,557 | Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet. | Cell Rep | 2017 | https://conductscience.org/library/papers/28355557 | PubMed |
| 4 | 26,830,139 | Increased ghrelin signaling prolongs survival in mouse models of human aging through activation of sirtuin1. | Mol Psychiatry | 2016 | https://conductscience.org/library/papers/26830139 | PubMed |
| 5 | 19,812,359 | CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. | Am J Physiol Regul Integr Comp Physiol | 2009 | https://conductscience.org/library/papers/19812359 | PubMed |
| 6 | 28,883,883 | Atractylodin Induces Myosin Light Chain Phosphorylation and Promotes Gastric Emptying through Ghrelin Receptor. | Evid Based Complement Alternat Med | 2017 | https://conductscience.org/library/papers/28883883 | PubMed |
| 7 | 33,486,695 | Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model. | Arch Pharm Res | 2021 | https://conductscience.org/library/papers/33486695 | PubMed |
| 8 | 28,467,931 | Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. | Cell Metab | 2017 | https://conductscience.org/library/papers/28467931 | PubMed |
| 9 | 26,608,256 | Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. | Lancet | 2016 | https://conductscience.org/library/papers/26608256 | PubMed |
| 10 | 30,887,000 | AMPK activation protects against diet induced obesity through Ucp1-independent thermogenesis in subcutaneous white adipose tissue. | Nat Metab | 2019 | https://conductscience.org/library/papers/30887000 | PubMed |
1 to 10 of 50
See all 50 referencesCited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,795,341 | Pharmacological Effects and Proposed Mechanisms of Atractylodes Medicinal Plants in Liver Diseases: A Narrative Review. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42795341 | PubMed |
| 41,900,114 | Herbal Textual Research, Phytochemistry, Pharmacology and Toxicity of Atractylodis Rhizoma: A Comprehensive Review. | Molecules | 2026 | https://conductscience.org/library/papers/41900114 | PubMed |
| 41,373,959 | Lactiplantibacillus plantarum Ln4 Alleviates High-Fat Diet-Induced Obesity by Modulating Lipid Metabolism and Adipogenesis in C57BL/6 Mice. | Nutrients | 2025 | https://conductscience.org/library/papers/41373959 | PubMed |
| 40,999,974 | Atractylodin inhibits ferroptosis in sepsis‑induced acute gastrointestinal injury via SIRT3/PRDX3. | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40999974 | PubMed |
| 39,942,910 | A Comprehensive Review on Graptopetalum paraguayense's Phytochemical Profiles, Pharmacological Activities, and Development as a Functional Food. | Plants (Basel) | 2025 | https://conductscience.org/library/papers/39942910 | PubMed |
| 39,599,662 | Protective Effects of Isostrictiniin Against High-Fat, High-Sugar Diet-Induced Steatosis in MASLD Mice via Regulation of the AMPK/SREBP-1c/ACC Pathway. | Nutrients | 2024 | https://conductscience.org/library/papers/39599662 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39391981
GET https://conductscience.org/api/papers/v1/39391981/references?page=2